1. Home
  2. ABTS vs PBM Comparison

ABTS vs PBM Comparison

Compare ABTS & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABTS
  • PBM
  • Stock Information
  • Founded
  • ABTS 2010
  • PBM 1994
  • Country
  • ABTS Hong Kong
  • PBM Canada
  • Employees
  • ABTS N/A
  • PBM N/A
  • Industry
  • ABTS Computer Software: Programming Data Processing
  • PBM
  • Sector
  • ABTS Technology
  • PBM
  • Exchange
  • ABTS Nasdaq
  • PBM NYSE
  • Market Cap
  • ABTS 4.6M
  • PBM 5.3M
  • IPO Year
  • ABTS N/A
  • PBM N/A
  • Fundamental
  • Price
  • ABTS $3.79
  • PBM $5.20
  • Analyst Decision
  • ABTS
  • PBM
  • Analyst Count
  • ABTS 0
  • PBM 0
  • Target Price
  • ABTS N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • ABTS 366.3K
  • PBM 89.7K
  • Earning Date
  • ABTS 12-31-2024
  • PBM 07-07-2025
  • Dividend Yield
  • ABTS N/A
  • PBM N/A
  • EPS Growth
  • ABTS N/A
  • PBM N/A
  • EPS
  • ABTS N/A
  • PBM N/A
  • Revenue
  • ABTS $6,711,225.00
  • PBM N/A
  • Revenue This Year
  • ABTS N/A
  • PBM N/A
  • Revenue Next Year
  • ABTS N/A
  • PBM N/A
  • P/E Ratio
  • ABTS N/A
  • PBM N/A
  • Revenue Growth
  • ABTS 299.11
  • PBM N/A
  • 52 Week Low
  • ABTS $0.25
  • PBM $0.41
  • 52 Week High
  • ABTS $4.19
  • PBM $824.90
  • Technical
  • Relative Strength Index (RSI)
  • ABTS 53.78
  • PBM 60.63
  • Support Level
  • ABTS $2.91
  • PBM $3.41
  • Resistance Level
  • ABTS $9.40
  • PBM $4.80
  • Average True Range (ATR)
  • ABTS 1.01
  • PBM 0.77
  • MACD
  • ABTS 0.03
  • PBM 0.19
  • Stochastic Oscillator
  • ABTS 21.54
  • PBM 86.19

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: